H.C. Wainwright lowered the firm’s price target on Gritstone to $4 from $7 and keeps a Buy rating on the shares following the Q1 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRTS:
- Gritstone reports Q1 EPS (34c), consensus (32c)
- Gritstone highlights durability, potential utility of samRNA COVID-19 vaccine
- Gritstone Oncology Announces Board of Directors Changes
- Gritstone appoints Stephen Webster to board of directors
- Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors